Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 2 |
2023 | 3 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Activation of the PP2A-B56α heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation.
Blood. 2023 Mar 2;141(9):1047-1059. doi: 10.1182/blood.2022016466.
Blood. 2023.
PMID: 36455198
Free PMC article.
Regulation and role of the PP2A-B56 holoenzyme family in cancer.
Peris I, Romero-Murillo S, Vicente C, Narla G, Odero MD.
Peris I, et al.
Biochim Biophys Acta Rev Cancer. 2023 Sep;1878(5):188953. doi: 10.1016/j.bbcan.2023.188953. Epub 2023 Jul 10.
Biochim Biophys Acta Rev Cancer. 2023.
PMID: 37437699
Free article.
Review.
Item in Clipboard
Set Protein Is Involved in FLT3 Membrane Trafficking.
Marcotegui N, Romero-Murillo S, Marco-Sanz J, Peris I, Berrozpe BS, Vicente C, Odero MD, Arriazu E.
Marcotegui N, et al. Among authors: peris i.
Cancers (Basel). 2023 Apr 10;15(8):2233. doi: 10.3390/cancers15082233.
Cancers (Basel). 2023.
PMID: 37190162
Free PMC article.
Item in Clipboard
A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemia.
Arriazu E, Vicente C, Pippa R, Peris I, Martínez-Balsalobre E, García-Ramírez P, Marcotegui N, Igea A, Alignani D, Rifón J, Mateos MC, Cayuela ML, Nebreda AR, Odero MD.
Arriazu E, et al. Among authors: peris i.
Blood Cancer J. 2020 Jan 8;10(1):3. doi: 10.1038/s41408-019-0270-0.
Blood Cancer J. 2020.
PMID: 31913266
Free PMC article.
Item in Clipboard
A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity.
Vicente C, Arriazu E, Martínez-Balsalobre E, Peris I, Marcotegui N, García-Ramírez P, Pippa R, Rabal O, Oyarzábal J, Guruceaga E, Prósper F, Mateos MC, Cayuela ML, Odero MD.
Vicente C, et al. Among authors: peris i.
Cancer Lett. 2020 Jan 1;468:1-13. doi: 10.1016/j.canlet.2019.10.007. Epub 2019 Oct 5.
Cancer Lett. 2020.
PMID: 31593801
Item in Clipboard
Cite
Cite